Jason Valent, MD¹, Michaela Liedtke, MD², Jeffrey A. Zonder, MD³, Mark Tulchinskiy, MD, MBA^4*, Chandrasekhar Udata, PhD^5*, Girly Ramirez, PhD^5*, Kate Szymaniak, PharmD, RPH^5*, Julia Catini, PharmD, MBA^5* and Candida Cristina Quarta, MD^5*

¹Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
²Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
³Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁴IQVIA Biotech, Morrisville, NC
⁵Alexion, AstraZeneca Rare Disease, Boston, MA

Christopher J. Ferreri, MD¹, Steven E. Quatela, MD, PhD^2*, Sean Aina^2*, Pourab Roy, MD, PhD^2*, Anita Boyapati, MD, PhD^2*, Karen Rodriguez Lorenc, MD², Glenn S. Kroog, MD^2* and Robert Z. Orlowski, MD, PhD¹

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Yael C Cohen^1*, Tamir Shragai, MD^2*, Noa Lavi, MD^3*, Iuliana Vaxman, MD, BA^4,5*, Evgeni Chubar, MD^6*, Moshe E Gatt⁷, Chezi Ganzel^8,9*, Hila Magen, MD^10*, Efrat Luttwak, MD^2*, Noa Lowenton-Spier^2*, Liron Gez-Aaronson^2*, Natan Melamed^2* and Irit Avivi, MD^11*

¹Tel Aviv Sourasky (Ichilov) Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
³Rambam Medical Center, Haifa, Israel
⁴Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
⁶Dpartment of Hematology, HaEmek Medical Center, Afula, Israel
⁷Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
⁸Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
⁹Shaare Zedek Medical Center, Jerusalem, Israel
¹⁰Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat-Gan, Israel
¹¹Division of Hematology, Tel Aviv University, Tel Aviv, Israel

Thierry Facon^1*, Shaji K Kumar, MD², Katja C. Weisel, MD³, Saad Usmani, MD⁴, Philippe Moreau, MD^5*, Torben Plesner⁶, Robert Z. Orlowski, MD, PhD⁷, Nizar Jacques Bahlis, MD⁸, Supratik Basu^9*, Hareth Nahi^10*, Cyrille Hulin^11*, Hang Quach¹², Michael O'Dwyer, MD¹³, Aurore Perrot, MD, PhD^14*, Christopher P. Venner^15*, Noopur Raje, MD¹⁶, Mourad Tiab^17*, Margaret Macro, MD^18*, Laurent Frenzel^19*, Xavier Leleu, MD, PhD²⁰, Huiling Pei, PhD^21*, Robin Carson²², Fredrik Borgsten^23* and Hartmut Goldschmidt, MD²⁴

¹University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
²Department of Hematology, Mayo Clinic Rochester, Rochester, MN
³Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
⁶Vejle Hospital and University of Southern Denmark, Vejle, Denmark
⁷Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁸Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
⁹Royal Wolverhampton NHS Trust and University of Wolverhampton, CRN West Midlands, NIHR, Wolverhampton, United Kingdom
¹⁰Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden
¹¹Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France
¹²University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
¹³Department of Medicine/Haematology, NUI, Galway, Ireland
¹⁴CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
¹⁵Department of Medical Oncology, Cross Cancer Institute, University of Alberta and BC Cancer – Vancouver Centre Group, Alberta, Canada
¹⁶Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
¹⁷CHD Vendée, La Roche sur Yon, France
¹⁸Centre Hospitalier Universitaire (CHU) de Caen, Caen, France
¹⁹Hôpital Necker-Enfants Malades, Paris, France
²⁰CHU Poitiers, Hôpital la Milétrie, Poitiers, France
²¹Janssen Research & Development, LLC, Titusville, NJ
²²Janssen Research & Development, Spring House, PA
²³Janssen Research & Development, Raritan, NJ
²⁴National Center for Tumor Diseases (NCT), University Clinic of Heidelberg, Internal Medicine V, Heidelberg, Germany

Iryna Dekhtiarenko, PhD^1*, Iva Lelios, PhD^2*, Jan Attig, PhD^2*, Nassim Sleiman, MSc^2*, Domenico Lazzaro, MD, PhD^2*, Emilie Schindler, PhD^2*, Jan Eckmann^3*, Pablo Umana, PhD¹, Wolfgang Jacob, PhD^3*, Meike Schneider, MD^2*, Carmelo Carlo-Stella, MD, PhD⁴, Rita Mazza, MD^5*, Salomon Manier, MD, PhD⁶, Thierry Facon^6*, Sung-Soo Yoon, MD, PhD^7,8, Youngil Koh, MD, PhD^8*, Simon J Harrison, MD^9,10, Jeremy Er, MD^11,12*, Antonio Pinto, MD^13*, Francesco Volzone, MD^13*, Giulia Perrone, MD^14*, Paolo Corradini, MD¹⁴, Titouan Cazaubiel, MD^15*, Cyrille Hulin^15*, Cyrille Touzeau^16*, Philippe Moreau, MD^17*, Enrique M. Ocio¹⁸, Carmen Maria Montes Gaisan, MD^18*, Rakesh Popat, MD, PhD^19*, Sarah Leong, MD^20*, Fritz Offner, MD, PhD²¹, Paula Rodriguez Otero^22*, Ana Alfonso-Pierola, MD, PhD^23*, Martin Hutchings, MD, PhD^24*, Caroline Hasselbalch Riley, MD, PhD^24* and Ann-Marie E Bröske^3*

¹Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Zurich, Switzerland
²Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland
³Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany
⁴Department of Oncology and Hematology, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
⁵Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
⁶CHU de Lille, Lille, France
⁷Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
⁸Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁹Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
¹⁰Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
¹¹Department of Clinical Haematology, Peter MacCallum Cancer Center and Royal Melbourne Hospital, Melbourne, Australia
¹²The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
¹³Istituto Nazionale dei Tumori “Fondazione G Pascale”, IRCCS, Napoli, Italy
¹⁴IRCCS Istituto Nazionale dei Tumori, Milan, Italy
¹⁵CHU de Bordeaux, Bordeaux, France
¹⁶Centre Hospitalier Universitaire (CHU) de Nantes, INSERM, Université de Nantes, Nantes, France
¹⁷CHU de Nantes, Nantes, France
¹⁸Hospital Universitario Marques de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
¹⁹Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²⁰University College London Hospitals NHS Foundation Trust, London, United Kingdom
²¹Universitair Ziekenhuis Gent, Ghent, Belgium
²²Clinica Universidad de Navarra, Navarra, Spain
²³Department of Hematology, Clinica Universidad de Navarra, Navarra, Spain
²⁴Rigshospitalet, Copenhagen, Denmark

Naresh Bumma, MD¹, Joshua Richter, MD², Jason Brayer, MD, PhD³, Jeffrey A. Zonder, MD⁴, Madhav Dhodapkar, MBBS⁵, Mansi R. Shah, MD⁶, James E. Hoffman, MD^7*, Raya Mawad, MD^8*, Joseph J. Maly, MD⁹, Suzanne Lentzsch, MD, PhD^10*, Attaya Suvannasankha, MD^11*, Pourab Roy, MD, PhD^12*, Jyotirmoy Dey, PhD^12*, Dhruti Chokshi, BS^12*, Anita Boyapati, MD, PhD^12*, Jenn Visich, PhD^12*, Yariv Houvras, MD, PhD^12*, Karen Rodriguez Lorenc, MD¹², Glenn S. Kroog, MD^12* and Sundar Jagannath²

¹The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Icahn School of Medicine at Mount Sinai, New York, NY
³H. Lee Moffitt Cancer Center, Tampa, FL
⁴Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁵Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁶Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁷University of Miami Health System, Miami, FL
⁸Swedish Center for Blood Disorders and Cellular Therapy, Seattle, WA
⁹Norton Cancer Institute, Louisville, KY
¹⁰Columbia University Medical Center, New York, NY
¹¹Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN
¹²Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Shaji K Kumar, MD¹, Betsy Laplant, MS^2*, Erik J Asmus^3*, Francis K. Buadi, MB⁴, Wilson I. Gonsalves, MD⁵, Eli Muchtar, MD⁶, David Dingli, MD, PhD⁷, Melanie Ann Thompson^8*, Ronald Go, MD⁷, Rahma M Warsame, MD¹, Taxiarchis Kourelis, MD⁷, Yi L. Hwa, NP⁷, Amie Fonder, PA-C^7*, Miriam A. Hobbs, APRN, CNP, DNP^7*, Martha Q. Lacy, MD⁹, Angela Dispenzieri, MD⁸, Suzanne R. Hayman, MD⁷, Nelson Leung, MD¹⁰, Moritz Binder, MD, MPH⁷, S. Vincent Rajkumar, MD¹¹, Morie A Gertz, MD¹² and Prashant Kapoor, MD¹

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Biomedical Statistics and Informatics, Mayo Clinic, Rochester
⁴Mayo clinic college of medicine, Rochester, MN
⁵Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
⁶Associate Professor of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Mayo Clinic, Rochester, MN
⁹Division of Hematology, Mayo Clinic Rochester, Rochester, MN
¹⁰Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
¹¹Mayo Clinic College of Medicine, Rochester, MN
¹²Division of Hematology, Department of Internal Medicine, Mayo Clinic, ROCHESTER, MN

Natalie Callander, MD¹, Rebecca Silbermann, MD, MMS², Jonathan L. Kaufman, MD³, Kelly N. Godby, MD^4*, Jacob P Laubach, MD^5*, Timothy Martin Schmidt, MD¹, Douglas W Sborov^6*, Eva Medvedova, MD^2*, Brandi Reeves, MD⁷, Binod Dhakal, MBBS⁸, Cesar Rodriguez, MD^9*, Saurabh Chhabra, MD, MS¹, Ajai Chari^10*, Susan Bal^11*, Larry D. Anderson Jr., MD, PhD¹², Bhagirathbhai Dholaria, MBBS¹³, Nitya Nathwani, MD¹⁴, Parameswaran Hari, MD, MRCP¹⁵, Nina Shah, MD¹⁶, Naresh Bumma, MD¹⁷, Sarah A. Holstein, MD, PhD¹⁸, Caitlin Costello, MD¹⁹, Andrzej Jakubowiak, MD, PhD²⁰, Tanya M. Wildes, MD^18*, Robert Z. Orlowski, MD, PhD²¹, Ken H. Shain, MD, PhD²², Andrew J. Cowan, MD^23*, Huiling Pei, PhD^24*, Annelore Cortoos, MD^25*, Sharmila Patel, PhD^25*, Thomas S. Lin, MD, PhD²⁵, Smith Giri, MD, MHS²⁶, Luciano J. Megala Costa, MD, PhD²⁷, Paul G. Richardson, MD²⁸, Saad Usmani, MD²⁹ and Peter M. Voorhees, MD^30*

¹University of Wisconsin Carbone Cancer Center, Madison, WI
²Knight Cancer Institute, Oregon Health & Science University, Portland, OR
³Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁴Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Hospital, Birmingham, AL
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶University of Utah Huntsman Cancer Institute, Salt Lake City, UT
⁷University of North Carolina – Chapel Hill, Chapel Hill, NC
⁸Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
⁹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁰Icahn School of Medicine at Mount Sinai, New York, NY
¹¹University of Alabama at Birmingham Hospital, Birmingham, AL
¹²Myeloma, Waldenstrom’s and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
¹³Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
¹⁴Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁵Medical College of Wisconsin, Milwaukee, WI
¹⁶University of California San Francisco, San Francisco, CA
¹⁷Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁸Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
¹⁹Moores Cancer Center, University of California San Diego, La Jolla, CA
²⁰Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
²¹Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
²²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²³Division of Medical Oncology, University of Washington, Seattle, WA
²⁴Janssen Research & Development, LLC, Titusville, NJ
²⁵Janssen Scientific Affairs, LLC, Horsham, PA
²⁶UAB School of Medicine Hematology & Oncology, Birmingham, AL
²⁷University of Alabama at Birmingham Hospital, Vestavia, AL
²⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²⁹Memorial Sloan Kettering Cancer Center, New York, NY
³⁰Levine Cancer Institute, Atrium Health Wake Forest Baptist, Charlotte, NC

Amrita Y. Krishnan, MD, FACP¹, Salomon Manier^2*, Evangelos Terpos, MD, PhD³, Saad Usmani, MD⁴, Josephine Khan^5*, Rachel Pearson^5*, Suzette Girgis⁶, Yue Guo^6*, Dana McAleer^6*, Yunsi Olyslager^7*, Tobias Kampfenkel⁸ and Niels W.C.J. van de Donk⁹

¹City of Hope Comprehensive Cancer Center, Duarte, CA
²University of Lille, Lille, France
³University of Athens, Athens, Greece
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Janssen Research & Development, High Wycombe, United Kingdom
⁶Janssen Research & Development, Spring House, PA
⁷Janssen Research & Development, Beerse, Belgium
⁸Janssen Research & Development, Neuss, Germany
⁹Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Shaji K Kumar, MD¹, Philippe Moreau, MD^2*, Nizar Jacques Bahlis, MD³, Thierry Facon^4*, Torben Plesner⁵, Robert Z. Orlowski, MD, PhD⁶, Supratik Basu^7*, Hareth Nahi^8*, Cyrille Hulin^9*, Hang Quach¹⁰, Hartmut Goldschmidt, MD¹¹, Michael O'Dwyer, MD¹², Aurore Perrot, MD, PhD^13*, Christopher P. Venner^14*, Katja C. Weisel, MD¹⁵, Noopur Raje, MD¹⁶, Mourad Tiab^17*, Margaret Macro, MD^18*, Laurent Frenzel^19*, Xavier Leleu, MD, PhD²⁰, Huiling Pei, PhD^21*, Maria Krevvata^22*, Robin Carson²³, Fredrik Borgsten^24* and Saad Usmani, MD²⁵

¹Department of Hematology, Mayo Clinic Rochester, Rochester, MN
²Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
³Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
⁴Centre Hospitalier Universitaire (CHU) Lille, Service des Maladies du Sang, University of Lille, Lille, France
⁵Vejle Hospital and University of Southern Denmark, Vejle, Denmark
⁶Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁷Royal Wolverhampton NHS Trust and University of Wolverhampton, CRN West Midlands, NIHR, Wolverhampton, United Kingdom
⁸Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden
⁹Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France
¹⁰St Vincent's Hospital Melbourne, University of Melbourne, Melbourne, Australia
¹¹University Hospital Heidelberg, Internal Medicine and National Center for Tumor Diseases (NCT), Heidelberg, Germany
¹²Department of Medicine/Haematology, NUI, Galway, Ireland
¹³CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
¹⁴Department of Medical Oncology, Cross Cancer Institute, University of Alberta and BC Cancer – Vancouver Centre Group, Alberta, Canada
¹⁵Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁶Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
¹⁷CHD Vendée, La Roche sur Yon, France
¹⁸Centre Hospitalier Universitaire (CHU) de Caen, Caen, France
¹⁹Hôpital Necker-Enfants Malades, Paris, France
²⁰CHU Poitiers, Hôpital la Milétrie, Poitiers, France
²¹Janssen Research & Development, LLC, Titusville, NJ
²²Janssen Research & Development, LLC, Spring House, PA
²³Janssen Research & Development, Spring House, PA
²⁴Janssen Research & Development, Raritan, NJ
²⁵Memorial Sloan Kettering Cancer Center, New York, NY

Ajay K. Nooka, MD, MPH, FACP¹, Jonathan L. Kaufman, MD², Cesar Rodriguez, MD^3*, Andrzej Jakubowiak, MD, PhD⁴, Yvonne A. Efebera, MD, MPH⁵, Brandi Reeves, MD⁶, Tanya M. Wildes, MD^7*, Sarah A. Holstein, MD, PhD⁷, Larry D. Anderson Jr., MD, PhD⁸, Ashraf Z. Badros, MD⁹, Leyla O. Shune, MD¹⁰, Ajai Chari^11*, Huiling Pei, PhD^12*, Annelore Cortoos, MD^13*, Sharmila Patel, PhD^13*, Thomas S. Lin, MD, PhD¹³, Paul G. Richardson, MD¹⁴, Saad Usmani, MD¹⁵ and Peter M. Voorhees, MD^16*

¹Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
²Winship Cancer Institute of Emory University Hospital, Atlanta, GA
³Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴University of Chicago Medical Center, Chicago, IL
⁵OhioHealth, Columbus, OH
⁶University of North Carolina at Chapel Hill, Chapel Hill, NC
⁷Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
⁸Myeloma, Waldenstrom’s and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁹Greenbaum Cancer Center, University of Maryland, Baltimore, MD
¹⁰Division of Hematologic Malignancies and Cellular Therapeutics (HMCT), University of Kansas Medical Center, Kansas City, KS
¹¹Icahn School of Medicine at Mount Sinai, New York, NY
¹²Janssen Research & Development, LLC, Titusville, NJ
¹³Janssen Scientific Affairs, LLC, Horsham, PA
¹⁴Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
¹⁵Memorial Sloan Kettering Cancer Center, New York, NY
¹⁶Levine Cancer Institute, Atrium Health Wake Forest Baptist, Charlotte, NC

Maria-Victoria Mateos, MD¹, Jesús San-Miguel, MD, PhD², Michele Cavo, MD^3*, Joan Bladé Creixenti, MD, PhD⁴, Kenshi Suzuki⁵, Andrzej Jakubowiak, MD, PhD⁶, Stefan Knop^7*, Chantal Doyen, MD⁸, Paulo Lucio, MD, PhD^9*, Zsolt Nagy, MD, PhD^10*, Ludek Pour, MD, Prof, PhD^11*, Sebastian Grosicki, MD, PhD¹², Andre H Crepaldi, MD^13*, Anna Marina Liberati¹⁴, Philip Campbell, MB, ChB^15*, Tatiana Shelekhova^16*, Sung-Soo Yoon, MD, PhD¹⁷, Genadi Iosava, MD^18*, Tomoaki Fujisaki^19*, Mamta Garg, MD, FRCP, FRCPath^20*, Huiling Pei, PhD^21*, Maria Krevvata^22*, Robin Carson²², Fredrik Borgsten^23* and Meletios A. Dimopoulos, MD²⁴

¹University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain
²Clínica Universidad de Navarra, CCUN, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain
³Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁴Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⁵Department of Hematology, Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan
⁶University of Chicago Medical Center, Chicago, IL
⁷Nuremberg General Hospital, Department of Hematology, Oncology and Stem Cell Transplantation, Paracelsus Medical School, Nuremberg, Germany
⁸Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
⁹Champalimaud Centre for the Unknown, Lisbon, Portugal
¹⁰Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Na, Hungary
¹¹University Hospital Brno, Brno, Czech Republic
¹²Department of Hematology and Cancer Prevention in Chorzów, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, Katowice, Poland
¹³Clinica de Tratamento E, Cuiaba, Brazil
¹⁴Università degli studi di Perugia, Azienda Ospedaliera Santa Maria, Terni, Italy
¹⁵Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Australia
¹⁶Clinic of Professional Pathology, Saratov, RUS
¹⁷Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
¹⁸Medinvest-Institute of Hematology, Tbilisi, Georgia
¹⁹Matsuyama Red Cross Hospital, Matsuyama, Japan
²⁰Haematology Department, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
²¹Janssen Research & Development, LLC, Titusville, NJ
²²Janssen Research & Development, LLC, Spring House, PA
²³Janssen Research & Development, LLC, Raritan, NJ
²⁴National and Kapodistrian University of Athens, Athens, Greece

James E. Hoffman, MD^1*, Brea Lipe, MD², Jason Melear, MD³, Michaela Liedtke, MD⁴, Mark A. Schroeder, MD⁵, Ruben Niesvizky, MD⁶, Christopher Strouse, MD⁷, Christopher A. Yasenchak, MD⁸, Damian J. Green, MD⁹, Jeremy Sauer, PhD^10*, Yinghui Wang, MS^10*, Phoenix Ho, MD¹⁰ and Al-Ola Abdallah, MD¹¹

¹Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
³Texas Oncology, Austin, TX
⁴Stanford University Medical Center, Stanford, CA
⁵Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
⁶Weill Cornell Medicine, New York, NY
⁷Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
⁸Willamette Valley Cancer Institute and Research Center, Eugene, OR
⁹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹⁰Seagen Inc., Bothell, WA
¹¹University of Kansas Medical Center, Kansas City, KS

Vaishali Sanchorawala, MD¹, Michael Rosenzweig, MD, MS², Christopher Pericone^3*, Sandra Y. Vasey, MSc^4*, Xiang Qin^4*, Sonja Marie Kotoulek, BS^4*, Bart Vandael, RN^5*, Joana Duran^3*, Samer Khaled^6*, NamPhuong Tran^6* and Efstathios Kastritis, MD^7*

¹Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA
²Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA
³Janssen Research & Development, LLC, Raritan, NJ
⁴Janssen Research & Development, LLC, Spring House, PA
⁵Janssen Research and Development, Beerse, Belgium
⁶Janssen Research & Development, LLC, Los Angeles, CA
⁷Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Sikander Ailawadhi¹, Ricardo D Parrondo, MD², Gabriela Perez, MS^3*, Mohamed A. Kharfan-Dabaja, MD, MBA⁴, Hemant S. Murthy, MD⁴, Ernesto Ayala, MD⁵, Patrick J O'Brien^6*, Vivek Roy, MD⁷, Victoria R. Alegria^7*, Ashley Zimmerman^8*, Dustin Chapin^9*, Stephanie Lanier^10*, Carly Kasik^9*, Schannon Bradley^9*, Taimur Sher, MD², Aneel Paulus, MD¹ and Asher Chanan-Khan, MD¹¹

¹Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Division of Biostatistics and Informatics,, Mayo Clinic, Rochester, MN
⁴Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
⁵Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
⁶Mayo Clinic, Rochester, MN
⁷Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL
⁸Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁹Mayo Clinic, Jacksonville, FL
¹⁰4500 San Pablo Road, Mayo Clinic, JAcksonville, FL
¹¹Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL

Yuan Jian^1*, Long Chang^2*, Mingxia Shi^3*, Ying Sun^4*, Xiaoxia Chu^5*, Hua Xue^6*, Wenrong Huang^7*, Xuliang Shen^8*, Jie Ma^9*, Guorong Jia^10*, Yaqing Feng^11*, Zhenfang Xi^12*, Yanhong Zhao^13*, Yanping Ma^14*, Jing Xiao^15*, Guangyu Ma^16*, Qingming Wang^17*, Li Bao, MD, PhD^18*, Yujun Dong^19*, Hebing Zhou^20*, Chunyan Sun, MD^21*, Guohong Su^22*, Yan Yan^23*, Saiyin Qimuge^24*, Liping Su^25*, Jingnan Sun^26*, Weiwei Tian, MD^27*, Xiuli Sun^28*, Hongmei Jing^29*, Da Gao^30*, Wenming Chen, MD. PhD^1*, Jian Li, MD³¹ and Wen Gao, MD, PhD^1*

¹Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
²Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Beijing, China
³The First Affiliated Hospital of Kunming Medical University, Hematology Research Center of Yunnan Province, Kunming, China
⁴Chifeng Municipal Hospital, Chifeng, China
⁵Department of Hematology, Yantai Yuhuangding Hospital, Yantai, Shandong, China
⁶The Second Hospital of Hebei Medical University, Hebei, China
⁷The Fifth Medical Center of the General Hospital of the Chinese people's Liberation Army, Beijing, China
⁸Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China
⁹The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
¹⁰The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Secience and Technology, Baotou, China
¹¹The Third People's Hospital Of Datong, Datong, China
¹²Linfen People’s Hospital, Linfen, China
¹³The First Affiliated Hospital, Harbin Medical University, Harbin, China
¹⁴Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
¹⁵Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
¹⁶The Forth Hospital of Hebei Medical University, Shijiazhuang, China
¹⁷The Second Affiliated Hospital of Nanchang University, Nanchang, China
¹⁸Beijing Jishuitan Hospital, Beijing, China
¹⁹Department of Hematology, Peking University First Hospital, Beijing, China
²⁰Department of Hematology, Beijing Luhe Hospital,Capital Medical University, Beijing, China
²¹Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan, China
²²Cangzhou Central Hospital, Cangzhou, China
²³Bayannur Hospital, Bayannur, China
²⁴Ordos Central Hospital, Ordos, China
²⁵Department of Hematology, Shanxi Cancer Hospital, Taiyuan, China
²⁶The First Hospital of Jilin University, Changchun, China
²⁷Shanxi Bethune Hospital, Taiyuan, China
²⁸The First Affiliated Hospital of Dalian Medical University, Dalian, China
²⁹Department of Hematology, Third Hospital of Peking University, Beijing, China
³⁰The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, China
³¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Othman Salim Akhtar, MD¹, Jens Hillengass, MD, PhD², Brea Lipe, MD³, Sheila A. Figel, PhD^4*, Robert A. Fenstermaker, MD^4*, Michael J. Ciesielski, PhD^4* and Kelvin P. Lee, MD⁵

¹Moffitt Cancer Center, Buffalo, NY
²Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁴Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁵Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN

Ola Landgren, MD¹, Dickran Kazandjian, MD², Ashleigh O'Connell^3*, Gregory Finn, PhD^4* and Noopur Raje, MD⁵

¹Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami
³Pfizer Oncology, New York, NY
⁴Early Clinical Development, Pfizer Inc, Cambridge, MA
⁵Massachusetts General Hospital Cancer Center, Boston, MA

Sueh-li Lim, MBBS, FRACP, FRCPA^1,2, John Reynolds, PhD^3*, Hang Quach^4,5, Anna Hutchinson, FRACP, FRCPA, BMedSci, MBBS^6*, Ian H Kerridge, BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA^7,8*, Jane Estell, B.Med FRACP FRCPA⁹, Craig wallington-Gates, BSc, MBBS, MBiostat, PhD, FRACP, FRCPA^10,11*, Anna Kalff, MBBS, FRACP, FRCPA, PhD^1,2, Flora Yuen, BBiomedSc^12* and Andrew Spencer¹³

¹Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
²Malignant Haematology & Stem Cell Transplantation Services, Alfred Health, Melbourne, VIC, Australia
³Department of Haematology, The Alfred Hospital and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
⁴University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
⁵Clinical Haematology Service, St. Vincent’s Hospital, Melbourne, VIC, Australia
⁶Department of Haematology, Royal Hobart Hospital, Hobart, TAS, Australia
⁷University of Sydney, Sydney, NSW, Australia
⁸Royal North Shore Hospital, Sydney, NSW, Australia
⁹Haematology Department, Concord Cancer Centre, Concord Hospital, Concord, NSW, Australia
¹⁰Flinders Medical Centre-College of Medicine and Public Health, Flinders University, Centre for Cancer Biology, University of South Australia, Bedford Park, SA, Australia
¹¹SA Pathology, Adelaide, SA, Australia
¹²Malignant Haematology & Stem Cell Transplantation, Monash University, Melbourne, VIC, Australia
¹³Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia

Meral Beksac, MD¹, Tulin Tuglular, MD^2*, Francesca Gay, MD, PhD³, Roberto Mina, MD^3*, Eirini Katodritou, MD^4*, Ali Unal, MD⁵, Michele Cavo, MD^6*, Guner Hayri Ozsan, MD^7*, Vincent H.J. van der Velden, PhD^8*, Berna Beverloo, PhD^9*, Michael Vermeulen, BSc^10*, Mark van Duin, PhD^10*, Guldane Cengiz, MD^11*, Omur Gokmen Sevindik, MD¹, Serena Merante, MD^12*, Kyriaki Manousou, MSc^13*, Pieter Sonneveld, MD¹⁴ and Evangelos Terpos, MD, PhD¹⁵

¹Department of Hematology, Ankara University Faculty Of Medicine Cebeci Hospital, Ankara, Turkey
²Marmara University, İstanbul, Turkey
³University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
⁴Department of Haematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece
⁵Department of Hematology, Faculty of Medicine, Erciyes University, Melikgazi, Kayseri, Turkey
⁶Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁷Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Dokuz Eylul University, Izmir, Turkey
⁸Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
⁹Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands
¹⁰Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
¹¹Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey
¹²European Myeloma Network, Pavia, Italy
¹³Health Data Specialists, Dublin, Ireland
¹⁴Department of Hematology, Erasmus MC, Rotterdam, Netherlands
¹⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Omar Nadeem, MD¹, Robert A. Redd, MS^2*, Trevor J. Bayliss, MD^3*, Peter Barth, MD⁴, Jacob Laubach, MD⁵, Clifton C. Mo, MD⁶, Giada Bianchi, MD⁷, Kelly Masone, BA^1*, Kyle Griffin^8*, Lindsay Issokson^8*, Anna Barrell^8*, Randi Doherty^8*, Deborah Mailand^8*, Alexandra Distaso^5*, Sarah Patches^9*, Kathryn Goodrich^8*, Kathleen Oneill^8*, Vaishali Sanchorawala, MD¹⁰, Leyla O. Shune, MD¹¹ and Paul G. Richardson, MD¹²

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Berkshire Health Services, Pittsfield, MA
⁴Department of Medicine, Alpert Medical School of Brown University, Providence, RI
⁵Dana-Farber Cancer Institute, Boston, MA
⁶The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Amyloidosis Program, Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
⁸Dana-Farber Cancer Institute, Boston
⁹Dana Farber Cancer Insititute, Boston, MA
¹⁰Amyloidosis Center, Boston Medical Center Corporation, Boston, MA
¹¹Division of Hematologic Malignancies and Cellular Therapeutics (HMCT), University of Kansas Medical Center, Kansas City, KS
¹²Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics,, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Hanlon Sia, MBBS, FRACP, FRCPA^1*, Peter T. Tan, MBBS^2*, Joshua Richter, MD³, Phoebe Joy Ho, MBBS, DPhil, FRACP, FRCPA^4,5,6, Tara Cochrane, MBBS⁷, Hang Quach⁸, Binod Dhakal, MBBS⁹, Igor Proscurshim, MD^10*, Tony Jiang, MD PhD¹¹, Emaryn Mancino^11*, Yacine Salhi^11*, Sammicheli Stefano, PhD^12*, Girish Gudi, PhD^10*, Andrew Garton^11*, Eric J. Feldman, MD^11* and Andrew Spencer¹³

¹Pindara Private Hospital, Benowa, Australia
²One Clinical Research, Nedlands, Western Australia, Australia
³Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Royal Prince Alfred Hospital, Camperdown, NSW, Australia
⁵Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, Australia
⁶University of Sydney, Sydney, Australia
⁷Department of Haematology, Gold Coast University Hospital, Varsity Lakes, QLD, Australia
⁸Clinical Haematology Service, St. Vincent’s Hospital, Melbourne, VIC, Australia
⁹Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
¹⁰Ichnos Sciences, New York, NY
¹¹Ichnos Sciences, New York
¹²Ichnos Sciences, La Chaux-de-Fonds, Switzerland
¹³The Alfred Hospital and Monash University, Melbourne, VIC, Australia

Heinz Ludwig, MD¹, Thomas Melchardt, Assoc. Prof., MD, PhD^2*, Siegfried Sormann^3*, Niklas Zojer, MD^4*, Johannes Andel, MD^5*, Bernd L. Hartmann, MD^6*, Christoph Tinchon, MD^7*, Eberhard Gunsilius, MD^8*, Klaus Podar, MD, PhD⁹, Alexander Egle, MD², Wolfgang Willenbacher, MD, PhD^8,10, Ewald Wöll, MD^11*, Martin Schreder, MD^4*, Reinhard Ruckser, MD¹², Boris Bozic, MD^12*, Maria-Theresa Krauth, MD^13*, Andreas Petzer, Univ. Prof., MD¹⁴, Clemens A. Schmitt, Univ. Prof., MD¹⁵, Sigrid Machherndl-Spandl, MD^16*, Hermine Agis, MD¹³, Michael Fillitz, MD^17*, Song-Yau Wang, MD^18*, Stefan Knop, M.D.^19*, Sarah Kainz, MSc MSc^1*, Bruno Paiva^20* and Richard Greil, MD²

¹Wilhelminen Cancer Research Institute, Vienna, Austria
²Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria
³Department of Internal Medicine, Division Haematology, Medical University of Graz, Graz, AUT
⁴Department of Medicine I, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
⁵Department of Internal Medicine II, Pyhrn-Eisenwurzen Klinikum Steyr, Steyr, Austria
⁶Department of Internal Medicine II: Oncology, Hematology, Gastroenterology, Infectiology, Feldkirch Academic Teaching Hospital, Rankweil, Austria
⁷Department of Internal Medicine, LKH Hochsteiermark, Leoben, Austria
⁸Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria
⁹Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems, Lower Austria, Austria
¹⁰syndena GmbH, connect to cure, Innsbruck, Austria
¹¹Department of Internal Medicine, KH Zams, Zams, Austria
¹²Department of Medicine II, Clinic Donaustadt, Vienna, Austria
¹³Department of Internal Medicine I, Division Hematology & Hemostaseology, Medical University Vienna, Vienna, Austria
¹⁴Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Elisabethinen, Linz, Austria
¹⁵Department of Internal Medicine 3 – Hematology and Oncology, Kepler University Clinic, Johannes Kepler University, Linz, Austria
¹⁶Ordensklinikum Linz Elisabethinen, Linz, Austria
¹⁷Department of Internal Medicine, Hanusch Hospital, Vienna, Austria
¹⁸Medical Clinic and Polyclinic I, University HClinic Leipzig, Leipzig, Germany
¹⁹Medical Clinic and Policlinic II, University Clinic Würzburg, Wuerzburg, Germany
²⁰Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA, CIBERONC), CIBER-ONC CB16/12/00369, Clínica Universidad de Navarra, Pamplona, Navarra, Spain

Jin Lu, MD¹, Yang Liu, PhD^2*, Jian Hou^3* and Juan Li, PhD⁴

¹Peking University People’s Hospital, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing, China
²Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China, Beijing, China
³Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
⁴The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou , Guangdong, China

Rakesh Popat^1*, William Wilson^2*, Marquita Camilleri, MD^3*, Karthik Ramasamy⁴, Matthew Streetly, MD⁵, Jonathan Sive^6*, Ceri Bygrave^7*, Reuben Benjamin, MD, PhD⁸, Michael A Chapman, PhD, MRCP, FRCPath⁹, Selina J Chavda, MBBS, BSc, MRCP, FRCPATH^3*, Beth Phillips^10*, Maria del Mar Cuadrado, MBBS^11*, Gavin Pang^2*, Richard Jenner, BSc^2*, Tushhar Dadaga, BSc^2*, Sumaiya Kamora, BSc^2*, Ruth M. de Tute^12*, James Cavenagh, MD¹³, Laura Clifton-Hadley, BSc, PhD^14*, Roger G Owen^12* and Kwee Yong^15*

¹University College London Hospitals, NHS Foundation Trust, London, United Kingdom
²Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
³Cancer Institute, University College London, London, United Kingdom
⁴Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁵Department of Haematology, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom
⁶Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁷Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom
⁸Department of Haematology, Kings College Hospital NHS Foundation Trust, London, CA, United Kingdom
⁹MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom
¹⁰Division of Cancer Sciences, University of Manchester and the Christie Hospital, Manchester, United Kingdom
¹¹Department of Haematology, University College London Hospitals, London, United Kingdom
¹²HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹³Department of Haematology, Barts Health NHS Trust, London, United Kingdom
¹⁴Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
¹⁵Cancer Institute, Department of Haematology, University College London, London, United Kingdom

Vittorio Montefusco, MD^*, Anna Maria Cafro, MD^*, Gloria Margiotta Casaluci, MD^*, Francesca Patriarca, MD, PhD^*, Roberto Mina, MD^*, Mattia D'Agostino, MD^*, Andrea Capra, MScEng^*, Claudia Priola, MSc^*, Anna Benedetta Dalla Palma, MD^*, Rita Rizzi, MD^*, Angelo Genua, MD^*, Maria Teresa Petrucci, MD, Laura Paris, MD^*, Angelo Belotti, MD^*, Michele Cavo, MD^*, Concetta Conticello, MD, PhD^*, Carmelo Carlo-Stella, MD, PhD and Mario Boccadoro, MD^*

European Myeloma Network, EMN, Italy